论文部分内容阅读
全国人大代表、河北承德颈复康药业董事长李沈明接受本刊记者专访虽然药品招标在国内已经如火如荼地进行了十几年,但在每年的两会上,却总不可避免地听到代表和委员们对招标制度乃至政策发出的质疑声,他们将矛头直指药品招标中存在的弊病,并不遗余力地大声疾呼,为建立更完善的药品招标制度谏言。在今年的两会上,全国人大代表、河北承德颈复康药业董事长李沈明就药品招标问题接受了本刊记者专访,指出他对新一轮药品招标的看法及建议,同时在京津冀一体化的大背
National People’s Congress, Hebei Chengde neck rehabilitation pharmaceutical chairman Li Shenming interview with our correspondents Although the pharmaceutical tender has been in full swing in the country for more than 10 years, but in each of the two sessions, but always inevitably heard representatives and members They questioned the bidding system and even issued a policy. They will spearhead the shortcomings in drug bidding and spared no effort in loudly urging them to establish a better bidding system for medicines. At this year’s two sessions, Li Shenming, chairman of the National People’s Congress and chairman of Chengde JfK Pharmaceutical Co., Ltd., accepted an interview with this reporter on the issue of drug bidding and pointed out his opinions and suggestions on a new round of bidding for medicines. The big back